Details for New Drug Application (NDA): 211558
✉ Email this page to a colleague
NDA 211558 describes TROMETHAMINE, which is a drug marketed by B Braun Medical Inc and Milla Pharms and is included in two NDAs. It is available from one supplier. Additional details are available on the TROMETHAMINE profile page.
The generic ingredient in TROMETHAMINE is tromethamine. There are twenty-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the tromethamine profile page.
The generic ingredient in TROMETHAMINE is tromethamine. There are twenty-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the tromethamine profile page.
Summary for 211558
| Tradename: | TROMETHAMINE |
| Applicant: | B Braun Medical Inc |
| Ingredient: | tromethamine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 211558
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INJECTION | Strength | 18GM/500ML (3.6GM/100ML) | ||||
| Approval Date: | Dec 9, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
